Abstract Details

Title Genetic Contribution of PGRN, MAPT, VCP, and CHMP2B to the Etiology of Frontotemporal Dementia

Topic Neurogenetics and Gene Therapy

Presentation(s) (-)

Poster/Presentation
Number 002

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Julie Van Der Zee	No disclosure on file
	No disclosure on file
Sebastiaan Engelborghs, MD, PhD (University of Antwerp, Biomedical Sciences)	No disclosure on file
Diana Richardson, MD (VA Medical Center)	No disclosure on file
Andrew P. Slivka, Jr., MD (Dept of Neurology)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Kristel Sleegers	No disclosure on file
Jean-Jacques Martin, MD (Universiteit Antwerpen (formerly))	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Peter P. De Deyn, MD, PhD	Dr. De Deyn has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier.
	No disclosure on file
Alexis Brice, MD	Dr. Brice has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for ICM.
	No disclosure on file

��ɫ����